000268503 001__ 268503
000268503 005__ 20250411152834.0
000268503 0247_ $$2pmc$$apmc:PMC11019222
000268503 0247_ $$2doi$$a10.5664/jcsm.10854
000268503 0247_ $$2pmid$$apmid:37811906
000268503 0247_ $$2ISSN$$a1550-9389
000268503 0247_ $$2ISSN$$a1550-9397
000268503 0247_ $$2altmetric$$aaltmetric:155299560
000268503 037__ $$aDZNE-2024-00249
000268503 041__ $$aEnglish
000268503 082__ $$a610
000268503 1001_ $$aDieter, Munker$$b0
000268503 245__ $$aPolysomnographic findings in the ultra-rare McLeod syndrome: further documentation of sleep apnea as a possible feature.
000268503 260__ $$aWestchester, Ill.$$b[Verlag nicht ermittelbar]$$c2024
000268503 3367_ $$2DRIVER$$aarticle
000268503 3367_ $$2DataCite$$aOutput Types/Journal article
000268503 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1744378064_16420
000268503 3367_ $$2BibTeX$$aARTICLE
000268503 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000268503 3367_ $$00$$2EndNote$$aJournal Article
000268503 520__ $$aMcLeod syndrome is a very rare multisystemic neurodegenerative disease linked to mutations in the XK gene. It has cardiac, neurologic, and neuromuscular manifestations and shares similarities with Huntington's disease. The aim of this study was to evaluate sleep patterns of patients affected by McLeod syndrome.This retrospective case series of four males who underwent diagnostic polysomnography (mean age 53.8 ± 2.5 years) includes self-reported and objective evaluation of sleep using the Epworth Sleepiness Scale, genetic tests, documentation of clinical course and features, and laboratory-based full-night attended video-polysomnography.In three out of four patients, an Epworth Sleepiness Scale score ≥ 7 was evident. The average apnea-hypopnea index was 45.0 ± 19.0, with predominantly obstructive phenotype in three patients and predominant central events (central sleep apnea syndrome) in one patient. A significantly increased periodic limb movement index during sleep was observed in all patients. All patients tolerated continuous positive airway pressure or pressure controlled therapy.Polysomnography of all patients confirmed sleep apnea syndrome as a feature of McLeod syndrome. Three patients were diagnosed with obstructive sleep apnea and one with central sleep apnea syndrome. In addition, periodic limb movement index was increased in all patients.Dieter M, Kevin P, Tobias V, et al. Polysomnographic findings in the ultra-rare McLeod syndrome: further documentation of sleep apnea as a possible feature. J Clin Sleep Med. 2024;20(3):339-344.
000268503 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000268503 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000268503 650_7 $$2Other$$aMcLeod syndrome
000268503 650_7 $$2Other$$aXK gene
000268503 650_7 $$2Other$$acentral sleep apnea
000268503 650_7 $$2Other$$aobstructive sleep apnea
000268503 650_7 $$2Other$$aperiodic limb movements
000268503 650_7 $$2Other$$apolysomnography
000268503 650_2 $$2MeSH$$aMale
000268503 650_2 $$2MeSH$$aHumans
000268503 650_2 $$2MeSH$$aMiddle Aged
000268503 650_2 $$2MeSH$$aSleep Apnea, Central
000268503 650_2 $$2MeSH$$aNeurodegenerative Diseases
000268503 650_2 $$2MeSH$$aRetrospective Studies
000268503 650_2 $$2MeSH$$aSleepiness
000268503 650_2 $$2MeSH$$aSleep Apnea Syndromes: complications
000268503 650_2 $$2MeSH$$aSleep Apnea Syndromes: diagnosis
000268503 650_2 $$2MeSH$$aDocumentation
000268503 650_2 $$2MeSH$$aNeuroacanthocytosis
000268503 7001_ $$0P:(DE-2719)9000983$$aPeikert, Kevin$$b1
000268503 7001_ $$aTobias, Veit$$b2
000268503 7001_ $$0P:(DE-2719)2811732$$aHermann, Andreas$$b3$$udzne
000268503 7001_ $$aLorenz, Nowak$$b4
000268503 7001_ $$aKathrin, Kahnert$$b5
000268503 7001_ $$aNikolaus, Kneidinger$$b6
000268503 7001_ $$aJuergen, Behr$$b7
000268503 7001_ $$aJan, Remi$$b8
000268503 7001_ $$aAdrian, Danek$$b9
000268503 773__ $$0PERI:(DE-600)2210082-9$$a10.5664/jcsm.10854$$gVol. 20, no. 3, p. 339 - 344$$n3$$p339 - 344$$tJournal of clinical sleep medicine$$v20$$x1550-9389$$y2024
000268503 8564_ $$uhttps://pub.dzne.de/record/268503/files/DZNE-2024-00249_Restricted.pdf
000268503 8564_ $$uhttps://pub.dzne.de/record/268503/files/DZNE-2024-00249_Restricted.pdf?subformat=pdfa$$xpdfa
000268503 909CO $$ooai:pub.dzne.de:268503$$pVDB
000268503 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000983$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000268503 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811732$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000268503 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000268503 9141_ $$y2024
000268503 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-22
000268503 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-22
000268503 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-22
000268503 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-22
000268503 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-22
000268503 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-22
000268503 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN SLEEP MED : 2022$$d2023-08-22
000268503 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-22
000268503 9201_ $$0I:(DE-2719)1511100$$kAG Hermann$$lTranslational Neurodegeneration$$x0
000268503 980__ $$ajournal
000268503 980__ $$aVDB
000268503 980__ $$aI:(DE-2719)1511100
000268503 980__ $$aUNRESTRICTED